Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P8
Near historical low
vs 5Y Ago
-6.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q1 2026 | -107.97% |
| Q4 2025 | 16.94% |
| Q3 2025 | -0.53% |
| Q2 2025 | 48.24% |
| Q1 2025 | -213.27% |
| Q4 2024 | 64.93% |
| Q3 2024 | 0.00% |
| Q2 2024 | -14.47% |
| Q1 2024 | -17.27% |
| Q4 2023 | -36.26% |
| Q3 2023 | -79.06% |
| Q2 2023 | 59.41% |
| Q1 2023 | -24.80% |
| Q4 2022 | -14.11% |
| Q3 2022 | 39.46% |
| Q2 2022 | -92.65% |
| Q1 2022 | -14.64% |
| Q4 2021 | 29.50% |
| Q3 2021 | -19.24% |
| Q2 2021 | -6.15% |
| Q1 2021 | 17.26% |
| Q4 2020 | -9.54% |
| Q3 2020 | 17.05% |
| Q2 2020 | 18.71% |
| Q1 2020 | -43.18% |
| Q4 2019 | -108.88% |
| Q3 2019 | 55.39% |
| Q2 2019 | -7.91% |
| Q1 2019 | -30.23% |
| Q4 2018 | 12.74% |
| Q3 2018 | -57.57% |
| Q2 2018 | 44.59% |
| Q1 2018 | -81.25% |
| Q4 2017 | 40.91% |
| Q3 2017 | -16.24% |
| Q2 2017 | -47.46% |
| Q1 2017 | -6.87% |
| Q4 2016 | 16.16% |
| Q3 2016 | 39.73% |
| Q2 2016 | -153.89% |